[Federal Register Volume 72, Number 208 (Monday, October 29, 2007)]
[Notices]
[Page 61124]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-21202]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Navy


Notice of Intent To Grant a Partially Exclusive Patent License; 
Oasis Diagnostics Corp

AGENCY: Department of the Navy, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of the Navy hereby gives notice of its intent 
to grant to Oasis Diagnostics Corp., a revocable, nonassignable, 
partially exclusive license to practice worldwide the Government owned 
inventions described in U.S. Patent No. 6,841,159 issued on January 11, 
2005, for ``Rapid Lateral Flow Assay for Determining Exposure to 
Mycobacterium Tuberculosis and other mycobacteria''; and related 
foreign filings (PCT/US 03/02311, EP/1478395, and AU/2003210662 filed) 
in the fields of detection of antibodies in present in oral fluids from 
the group saliva, oral rinse expectorant, oral mucosal transudate, 
gingival crevicular fluid, and phlegmuntil.

DATES: Anyone wishing to object to the grant of this license must file 
written objections along with supporting evidence, if any, not later 
than November 13, 2007.

ADDRESSES: Written objections are to be filed with the Office of 
Technology Transfer, Naval Medical Research Center, 503 Robert Grant 
Ave., Silver Spring, MD 20910-7500.

FOR FURTHER INFORMATION CONTACT: Dr. Charles Schlagel, Director, Office 
of Technology Transfer, Naval Medical Research Center, 503 Robert Grant 
Ave., Silver Spring, MD 20910-7500, telephone: 301-319-7428.

(Authority: 35 U.S.C. 207, 37 CFR Part 404)

    Dated: October 23, 2007.
T.M. Cruz,
Lieutenant, Judge Advocate General's Corps, U.S. Navy, Federal Register 
Liaison Officer.
 [FR Doc. E7-21202 Filed 10-26-07; 8:45 am]
BILLING CODE 3810-FF-P